Mar 26, 2020
COVID-19: What Those with Lung Disease Should Know
Mar 25, 2020
ArcherDX Receives Approval for Archer®MET Companion Diagnostic for TEPMETKO® (Tepotinib) in Advanced Non-Small Cell Lung Cancer in Japan
Mar 25, 2020
TEPMETKO® (Tepotinib) Approved in Japan for Advanced NSCLC with METex14 Skipping Alterations
Mar 24, 2020
Non-Small Cell Lung Cancer Treatment Market to Surpass US$ 39,395.2 Million, Globally, by the end of 2027 - CMI
Mar 19, 2020
Hansoh Pharma's Ameile (Almonertinib) Receives Marketing Authorization in China for Second-Line Treatment for Patients With EGFR T790M-Mutation Non-Small Cell Lung Cancer
Mar 16, 2020
2020 Market Spotlight: Small-Cell Lung Cancer (SCLC)
Mar 04, 2020
Insmed Announces Publication Discussing the Clinical Management of Common Respiratory Events Associated with ARIKAYCE® (Amikacin Liposome Inhalation Suspension) in the Journal Open Forum Infectious Disease
Feb 27, 2020
Global Lung Cancer Therapeutics Market: Growth, Trends & Forecasts (2020-2025)
Feb 26, 2020
FDA Advisory Committee Votes in Favor of Lilly's CYRAMZA® (ramucirumab) as First-Line Treatment for Metastatic EGFR-Mutated Non-Small Cell Lung Cancer
Feb 25, 2020
IO Biotech Announces Positive Outcome of Interim Analysis of Phase 2 Randomized Trial in First Line Non-small Cell Lung Cancer
Feb 25, 2020
Mirati Therapeutics Reports Year-End 2019 Financial Results And Recent Corporate Updates
Feb 20, 2020
Small Cell Lung Cancer Market Size is Expected to Increase at a CAGR of 13.2% for the Study Period (2017-2030) in the 7MM | Some Market Key Players - AstraZeneca, PharmaMar, EpicentRx, United Therapeutics, Ipsen, G1 Therapeutics, Otsuka Holdings, Takeda
Feb 17, 2020
Basal Cell Carcinoma Treatment Market Forecast, Trend Analysis & Competition Tracking - Global Market Insights 2020 to 2025
Feb 12, 2020
Leading Lung Cancer Expert Joins HealthMyne Clinical Advisory Board
Feb 10, 2020
Kanazawa University Research: Combined Drug Treatment for Lung Cancer and Secondary Tumors
Jan 29, 2020
Lilly Receives FDA Priority Review for the Selpercatinib New Drug Application
Jan 27, 2020
PharmaMar and Bionical Emas Launch Expanded Access Program for Lurbinectedin in Relapsed Small Cell Lung Cancer in the U.S.
Jan 21, 2020
LUNGevity and the ALK Positive Group Partner to Fund $1 Million in Lung Cancer Research Awards
Jan 19, 2020
Bridge Biotherapeutics Announces FDA IND Clearance for BBT-176, an EGFR TKI for NSCLC
Jan 16, 2020
Educational Lung Cancer Event Coming to Houston to Raise Awareness of State's High Rate of Lung Cancer